Clinical Trials Directory

Trials / Completed

CompletedNCT03202914

Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression

Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression: A Secondary Data Analysis of the Modification of Diet in Renal Disease (MDRD) Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
840 (actual)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The present record represents a secondary data analysis of the Modification of Diet in Renal Disease (MDRD) Study. For this analysis, the MDRD study data and specimens were retrieved from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Central Repository. A global, untargeted, metabolomic profile was used to investigate biomarkers of dietary intake as well as biomarkers of kidney disease progression.

Detailed description

The present study was conducted in order to: 1) quantify the metabolomic expression of dietary intake; and 2) examine the relationship between metabolites that reflect dietary intake and kidney disease progression. This secondary data analysis leverages the completed Modification of Diet in Renal Disease (MDRD) study, a randomized clinical trial of dietary protein restriction (N=840).

Conditions

Interventions

TypeNameDescription
BEHAVIORALUsual protein and phosphorus dietDiet intervention
BEHAVIORALLow protein and phosphorus dietDiet intervention
BEHAVIORALVery low protein and phosphorusDiet intervention

Timeline

Start date
1988-10-01
Primary completion
1993-05-01
Completion
2016-01-01
First posted
2017-06-29
Last updated
2017-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03202914. Inclusion in this directory is not an endorsement.